-
1
-
-
34250691058
-
-
A.W. McCormick, C.G. Whitney, M.M. Farley, R. Lynfield, L.H. Harrison, N.M. Bennet, W. Schaffner, A. Reingold, J. Hadler, P. Cieslak, M.H. Samore, and M. Lipsitch Nat. Med. 2003 1 7
-
(2003)
Nat. Med.
, pp. 1-7
-
-
McCormick, A.W.1
Whitney, C.G.2
Farley, M.M.3
Lynfield, R.4
Harrison, L.H.5
Bennet, N.M.6
Schaffner, W.7
Reingold, A.8
Hadler, J.9
Cieslak, P.10
Samore, M.H.11
Lipsitch, M.12
-
2
-
-
85030820890
-
-
U.S. Patent 5,635,485, 1997
-
Agouridas, C.; Chantot, J.-F.; Denis, A.; Solange, G. D.; Odile, L. M. U.S. Patent 5,635,485, 1997
-
-
-
Agouridas, C.1
Chantot, J.-F.2
Denis, A.3
Solange, G.D.4
Odile, L.M.5
-
3
-
-
0036239577
-
-
F.-J. Schmitz, J. Petridou, H. Jagusch, N. Astfalk, S. Scheuring, and S. Schwarz J. Antimicrob. Chemother. 49 2002 611 617
-
(2002)
J. Antimicrob. Chemother.
, vol.49
, pp. 611-617
-
-
Schmitz, F.-J.1
Petridou, J.2
Jagusch, H.3
Astfalk, N.4
Scheuring, S.5
Schwarz, S.6
-
5
-
-
0036343455
-
-
G.G. Zhanel, M. Walters, A. Noreddin, L.M. Vercaigne, A. Wierzbowski, J.M. Embil, A.S. Gin, S. Douthwaite, and D.J. Hoban Drugs 62 2002 1771 1804
-
(2002)
Drugs
, vol.62
, pp. 1771-1804
-
-
Zhanel, G.G.1
Walters, M.2
Noreddin, A.3
Vercaigne, L.M.4
Wierzbowski, A.5
Embil, J.M.6
Gin, A.S.7
Douthwaite, S.8
Hoban, D.J.9
-
9
-
-
0042710322
-
-
S. Djokic, G. Kobrehel, G. Lazarevski, N. Lopotar, and Z. Tamburasev J. Chem. Soc., Perkin Trans. 1 1986 1881
-
(1986)
J. Chem. Soc., Perkin Trans. 1
, pp. 1881
-
-
Djokic, S.1
Kobrehel, G.2
Lazarevski, G.3
Lopotar, N.4
Tamburasev, Z.5
-
10
-
-
85030823844
-
-
U.S. Patent 4,742,049, 1988
-
Baker, W. R.; Clark, J. D. U.S. Patent 4,742,049, 1988
-
-
-
Baker, W.R.1
Clark, J.D.2
-
11
-
-
0000184017
-
-
Y. Or, R. Clark, S. Wang, D. Chu, A. Nilius, R. Flamm, M. Mitten, P. Ewing, J. Alder, and Z. Ma J. Med. Chem. 43 2000 1045 1049
-
(2000)
J. Med. Chem.
, vol.43
, pp. 1045-1049
-
-
Or, Y.1
Clark, R.2
Wang, S.3
Chu, D.4
Nilius, A.5
Flamm, R.6
Mitten, M.7
Ewing, P.8
Alder, J.9
Ma, Z.10
-
13
-
-
85030820902
-
-
note
-
Crystallographic data for structure 11 in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication numbers CCDC 250316
-
-
-
-
14
-
-
85030825590
-
-
note
-
We have applied this procedure (Swern oxidation then methanolysis) to telithromycin. The telithromycin aglycon was successfully obtained in 55% yield
-
-
-
-
15
-
-
85030829526
-
-
note
-
The p-tolyl glycosides were designed and synthesized in-house. The protecting group scheme (i.e., 2-OBz) was chosen in order to direct the β-configuration at the anomeric center resulting from the glycosylation reaction
-
-
-
-
16
-
-
85030819220
-
-
note
-
4 and concentrated. Purification by silica gel chromatography (toluene-acetone) afforded glycosylated compounds
-
-
-
-
17
-
-
0037099395
-
-
V.V. Rostovtsev, L.G. Green, V.V. Fokin, and B. Sharpless Angew. Chem., Int. Ed. 114 2002 2596 2599
-
(2002)
Angew. Chem., Int. Ed.
, vol.114
, pp. 2596-2599
-
-
Rostovtsev, V.V.1
Green, L.G.2
Fokin, V.V.3
Sharpless, B.4
-
19
-
-
85030824435
-
-
note
-
7Na (M+Na): 557.30, found: 557.22
-
-
-
-
20
-
-
85030819073
-
-
note
-
8 (M+H): 553.3232, found: 553.3222
-
-
-
-
21
-
-
85030823040
-
-
note
-
11 (M+H): 829.5, found: 829.4
-
-
-
-
22
-
-
85030827015
-
-
note
-
13 (M+H): 949.4917, found: 949.4902
-
-
-
-
23
-
-
85030821459
-
-
note
-
12 (M+H): 933.5, found: 933.4
-
-
-
-
24
-
-
85030820794
-
-
note
-
10 (M+H):813.48, found: 813.48
-
-
-
|